Pharma Foods International Co Ltd
TSE:2929

Watchlist Manager
Pharma Foods International Co Ltd Logo
Pharma Foods International Co Ltd
TSE:2929
Watchlist
Price: 951 JPY -1.86% Market Closed
Market Cap: 26.7B JPY
Have any thoughts about
Pharma Foods International Co Ltd?
Write Note

Pharma Foods International Co Ltd
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pharma Foods International Co Ltd
Total Other Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
Pharma Foods International Co Ltd
TSE:2929
Total Other Income
ÂĄ209m
CAGR 3-Years
46%
CAGR 5-Years
29%
CAGR 10-Years
36%
GNI Group Ltd
TSE:2160
Total Other Income
ÂĄ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
PeptiDream Inc
TSE:4587
Total Other Income
-ÂĄ1k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Takara Bio Inc
TSE:4974
Total Other Income
ÂĄ163m
CAGR 3-Years
19%
CAGR 5-Years
2%
CAGR 10-Years
2%
S
StemRIM Inc
TSE:4599
Total Other Income
-ÂĄ1.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Cuorips Inc
TSE:4894
Total Other Income
-ÂĄ40.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Pharma Foods International Co Ltd
Glance View

Market Cap
26.7B JPY
Industry
Biotechnology

Pharma Foods International Co., Ltd. engages in the development and sale of functional food materials. The company is headquartered in Kyoto, Kyoto-Fu and currently employs 293 full-time employees. The company went IPO on 2006-06-12. The firm operates through three business segments. The Mail Order segment is engaged in the sale of supplement Tamagosamin, cosmetics Pearl Skin Lanchel and Derma QII Mild Peeling Gel, through advertising media such as televisions and radios. The Functional Materials segment is engaged in the development and sale of functional materials such as GABA, Bonepep, Folic Acid eggs and Chicken Egg Antibody. The firm is also engaged in the planning and sale of original equipment manufacturer (OEM) products such as supplements and beverages. The Biomedical segment is engaged in the antibody contract manufacture business for drug discovery and diagnostics, and life science information (LSI) business for analysis and efficacy evaluation test of materials and products.

Intrinsic Value
2 625.98 JPY
Undervaluation 64%
Intrinsic Value
Price

See Also

What is Pharma Foods International Co Ltd's Total Other Income?
Total Other Income
209m JPY

Based on the financial report for Jul 31, 2024, Pharma Foods International Co Ltd's Total Other Income amounts to 209m JPY.

What is Pharma Foods International Co Ltd's Total Other Income growth rate?
Total Other Income CAGR 10Y
36%

Over the last year, the Total Other Income growth was 135%. The average annual Total Other Income growth rates for Pharma Foods International Co Ltd have been 46% over the past three years , 29% over the past five years , and 36% over the past ten years .

Back to Top